Epsilon Healthcare Limited (ASX:EPN)
Australia · Delayed Price · Currency is AUD 0.0320
-0.0010 (-3.03%)
Jan 30, 2026, 3:07 PM AEST
Epsilon Healthcare Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| 6.13 | 5.6 | 6.65 | 4.65 | 5.5 | 6.95 | Upgrade | |
Revenue Growth (YoY) | -1.24% | -15.81% | 42.99% | -15.39% | -20.93% | 45.09% | Upgrade |
Cost of Revenue | 2.75 | 1.43 | 1.84 | 3.42 | 3.57 | 4.61 | Upgrade |
Gross Profit | 3.39 | 4.17 | 4.81 | 1.24 | 1.92 | 2.34 | Upgrade |
Selling, General & Admin | 7.49 | 6.9 | 5.57 | 6.11 | 8.62 | 11.07 | Upgrade |
Research & Development | - | - | 0.05 | - | 0.17 | 0.47 | Upgrade |
Operating Expenses | 8.33 | 8.41 | 7.23 | 7.62 | 11.09 | 13.14 | Upgrade |
Operating Income | -4.95 | -4.24 | -2.42 | -6.39 | -9.17 | -10.8 | Upgrade |
Interest Expense | -1.47 | -1.15 | -0.52 | -0.4 | -0.87 | -0.6 | Upgrade |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.01 | -0 | -0.03 | 0 | Upgrade |
Other Non Operating Income (Expenses) | 0.5 | 0.47 | 0 | 1.34 | 2.48 | 0.86 | Upgrade |
EBT Excluding Unusual Items | -5.93 | -4.93 | -2.94 | -5.45 | -7.59 | -10.54 | Upgrade |
Impairment of Goodwill | - | - | - | - | -0.97 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -0.37 | -0.01 | - | - | Upgrade |
Asset Writedown | - | - | - | -6.91 | -1.54 | - | Upgrade |
Other Unusual Items | -0.86 | -0.7 | - | -1.77 | - | - | Upgrade |
Pretax Income | -6.79 | -5.63 | -3.31 | -14.14 | -10.11 | -10.54 | Upgrade |
Income Tax Expense | -0.67 | -0.13 | -2.22 | -0.54 | -0.86 | - | Upgrade |
Net Income | -6.12 | -5.49 | -1.09 | -13.61 | -9.24 | -10.54 | Upgrade |
Net Income to Common | -6.12 | -5.49 | -1.09 | -13.61 | -9.24 | -10.54 | Upgrade |
Shares Outstanding (Basic) | 368 | 345 | 300 | 252 | 193 | 159 | Upgrade |
Shares Outstanding (Diluted) | 368 | 345 | 300 | 252 | 193 | 159 | Upgrade |
Shares Change (YoY) | 22.28% | 14.98% | 19.01% | 30.79% | 21.43% | 19.45% | Upgrade |
EPS (Basic) | -0.02 | -0.02 | -0.00 | -0.05 | -0.05 | -0.07 | Upgrade |
EPS (Diluted) | -0.02 | -0.02 | -0.00 | -0.05 | -0.05 | -0.07 | Upgrade |
Free Cash Flow | -4.89 | -3.5 | -0.8 | -1.31 | -6.13 | -9.93 | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.00 | -0.01 | -0.03 | -0.06 | Upgrade |
Gross Margin | 55.21% | 74.52% | 72.34% | 26.55% | 34.98% | 33.67% | Upgrade |
Operating Margin | -80.69% | -75.72% | -36.32% | -137.36% | -166.75% | -155.25% | Upgrade |
Profit Margin | -99.85% | -98.10% | -16.40% | -292.50% | -168.11% | -151.51% | Upgrade |
Free Cash Flow Margin | -79.82% | -62.56% | -12.08% | -28.15% | -111.56% | -142.79% | Upgrade |
EBITDA | -4.36 | -2.98 | -1.1 | -4.99 | -8.24 | -9.66 | Upgrade |
EBITDA Margin | -71.02% | -53.13% | -16.52% | -107.36% | -149.86% | -138.87% | Upgrade |
D&A For EBITDA | 0.59 | 1.27 | 1.32 | 1.4 | 0.93 | 1.14 | Upgrade |
EBIT | -4.95 | -4.24 | -2.42 | -6.39 | -9.17 | -10.8 | Upgrade |
EBIT Margin | -80.69% | -75.72% | -36.32% | -137.36% | -166.75% | -155.25% | Upgrade |
Advertising Expenses | - | 0 | 0.02 | 0.04 | 0.13 | 0.3 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.